AMN Healthcare Services (AMN)
(Delayed Data from NYSE)
$41.01 USD
-1.41 (-3.32%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $40.94 -0.07 (-0.17%) 7:58 PM ET
4-Sell of 5 4
A Value C Growth F Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$41.01 USD
-1.41 (-3.32%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $40.94 -0.07 (-0.17%) 7:58 PM ET
4-Sell of 5 4
A Value C Growth F Momentum B VGM
Zacks News
AMN Healthcare Services (AMN) Continue to Surge Higher?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in AMN Healthcare Services, Inc. (AMN).
AMN vs. ICLR: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
AMN vs. ICLR: Which Stock Is the Better Value Option?
BioTelemetry (BEAT) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
BioTelemetry (BEAT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
AMN Healthcare Services (AMN) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
AMN Healthcare (AMN) delivered earnings and revenue surprises of 9.09% and 0.08%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
AMN Healthcare Services (AMN) Q3 Earnings Preview: Here's What to Look Out For
by Zacks Equity Research
AMN Healthcare (AMN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for September 19th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
New Strong Sell Stocks for September 14th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
AMN Healthcare Services (AMN) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
AMN Healthcare (AMN) delivered earnings and revenue surprises of 5.06% and 4.36%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
New Strong Sell Stocks for June 15th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
New Strong Sell Stocks for June 12th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Unemployment Falls to Near 18-Year Low: 6 Winning Picks
by Swarup Gupta
Professional and business services led job gains, followed by healthcare and manufacturing.
AMN Healthcare Services (AMN) Enters Oversold Territory
by Zacks Equity Research
AMN Healthcare Services, Inc. (AMN) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock
Top 5 Stocks With Impressive Net Profit Margin
by Zacks Equity Research
Net profit margin can turn out to be an accurate point of reference to gauge the potential of a company's operations and cost-control measures.
5 Spectacular Earnings Charts
by Tracey Ryniec
Their shares are breaking out to new highs and they have excellent earnings surprise track records. What more could an investor want?
5 Stocks Near 52-Week High: Will These Scale Higher?
by Zacks Equity Research
These stocks have passed through a screen we ran to find those that are trading near their 52-week high levels and still have plenty of upside left.
Zacks.com highlights: Willdan Group, AMN Healthcare Services, Harsco, SP Plus and Lakeland Industries
by Zacks Equity Research
Zacks.com highlights: Willdan Group, AMN Healthcare Services, Harsco, SP Plus and Lakeland Industries
5 Stocks With a Handsome Net Profit Margin
by Zacks Equity Research
Net profit margin can turn out to be a potent point of reference to gauge the strength in a company operations and cost-control measures.
Zacks.com featured highlights include: Archer Daniels, AMN, Fluor, Fortinet and National General
by Zacks Equity Research
Zacks.com featured highlights include: Archer Daniels, AMN, Fluor, Fortinet and National General
5 Stocks Near 52-Week High With More Upside in Store
by Zacks Equity Research
These stocks have passed through a screen we ran to find those that are trading near their 52-week high levels and still have plenty of upside left.
Zacks Market Edge Highlights: Exxon, Diageo, GlaxoSmithKline, Micron and AMN
by Zacks Equity Research
Zacks Market Edge Highlights: Exxon, Diageo, GlaxoSmithKline, Micron and AMN
What All Investors Should Know about Trade Deficits and Recessions
by Tracey Ryniec
What's the trade deficit really about? And what are the key signals that may alert investors to an upcoming recession?
Retailers May Shake Healthcare: 4 Stocks for a Fit Portfolio
by Zacks Equity Research
Retailers foray into the healthcare space might shake the industry. Yet some established players still looks attractive.
5 Reasons Why Centene is an Attractive Bet for Investors
by Zacks Equity Research
Centene (CNC) can be considered a lucrative investment option on the back of top-line growth, inorganic strategies and a solid financial health.
Why Teladoc (TDOC) Stock Has More Than Doubled in a Year
by Zacks Equity Research
Teladoc (TDOC) continues to gain from high demand for its telehealth services.
The Zacks Analyst Blog Highlights: Burlington, Legg Mason, AMN, Schneider National and CBRE
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Burlington, Legg Mason, AMN, Schneider National and CBRE